| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $46.72M | $39.21M | $45.19M | $55.14M | $59.03M |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | – |
| Operating Income | – | – | – | – | – |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | $1.71B | -$39.37M | -$2.48B | $95.78M | -$1.68B |
| EPS (basic) | – | – | – | – | – |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – |